Spots Global Cancer Trial Database for A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors
Official Title: A Phase 1/2 First-in-Human Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors
Study ID: NCT03369223
Conditions
Study Description
Brief Summary: The purpose of this study is to determine whether BMS-986249 both by itself and in combination with Nivolumab is safe and tolerable in the treatment of advanced solid tumors
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution - 0005, Aurora, Colorado, United States
Local Institution - 0006, Denver, Colorado, United States
Local Institution - 0017, Miami, Florida, United States
Local Institution - 0024, Baltimore, Maryland, United States
Local Institution - 0001, Hackensack, New Jersey, United States
Local Institution - 0002, New York, New York, United States
Local Institution - 0003, New York, New York, United States
Local Institution - 0029, Cincinnati, Ohio, United States
Local Institution - 0013, Eugene, Oregon, United States
Local Institution - 0004, Philadelphia, Pennsylvania, United States
Local Institution - 0008, Greenville, South Carolina, United States
Local Institution - 0010, Austin, Texas, United States
Local Institution - 0009, Dallas, Texas, United States
Local Institution - 0021, Houston, Texas, United States
Local Institution - 0016, San Antonio, Texas, United States
Local Institution - 0011, Tyler, Texas, United States
Local Institution - 0012, Leesburg, Virginia, United States
Local Institution - 0007, Norfolk, Virginia, United States
Local Institution - 0018, Vancouver, Washington, United States
Local Institution - 0038, Buenos Aires, Distrito Federal, Argentina
Local Institution - 0052, Caba, Distrito Federal, Argentina
Local Institution - 0037, Buenos Aires, , Argentina
Local Institution - 0015, North Sydney, New South Wales, Australia
Local Institution - 0014, Adelaide, South Australia, Australia
Local Institution, Frankston, Victoria, Australia
Local Institution - 0047, Heidelberg, Victoria, Australia
Local Institution - 0026, Edmonton, Alberta, Canada
Local Institution - 0036, Santiago, Metropolitana, Chile
Local Institution - 0039, Helsinki, , Finland
Local Institution - 0030, Essen, , Germany
Local Institution - 0035, Hamburg, , Germany
Local Institution - 0031, Heidelberg, , Germany
Local Institution - 0048, Milan, , Italy
Istituto Nazionale Tumori Fondazione Pascale, Napoli, , Italy
A.O.U.Senese - Policl.S.Maria alle Scotte, Siena, , Italy
Local Institution - 0040, Warszawa, , Poland
Local Institution - 0045, Bucharest, , Romania
Local Institution - 0041, Craiova, , Romania
Local Institution - 0042, Badalona, Barcelona [Barcelona], Spain
Local Institution - 0022, Madrid, Madrid, Comunidad De, Spain
Local Institution - 0044, Barcelona, , Spain
Local Institution - 0023, Madrid, , Spain
Local Institution - 0050, Madrid, , Spain
Local Institution - 0043, Malaga, , Spain
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
